Skip to main content
. 2020 Apr 7;2020(4):CD012309. doi: 10.1002/14651858.CD012309.pub2

Qadir 2014.

Methods Study design: randomized controlled trial, parallel group
Unit of analysis: participants
Number randomized: 50 in total, 25 per group
Number of arms: 2
Enrollment start year: not reported
Length of follow‐up: 6 months
Sample size calculations: not reported
Losses to follow‐up: none
Participants Country: India
Age (mean (SD)): 43 (12.6) in the MMC group, 47.3 (11.5) in the EX‐DCR alone group
Females (n (%)): 36 (72) in total, 19 (76) in the MMC group, 17 (68) in the EX‐DCR alone group
Inclusion criteria: patients with primary acquired nasolacrimal duct obstruction
Exclusion criteria: presaccal obstructions, acute dacryocystitis, chronic granulomatous condition, longstanding chronic dacryocystitis with fibrosis of sac, chronic dacryocystitis with fistula, ectropion, entropion, nasal conditions like severe deviated nasal septum, atrophic rhinitis, previous failure of DCR
Study group differences: no significant difference in ages; female preponderance in the study but no significant between‐group differences
Interventions Intervention: EX‐DCR with application of 0.2 mg/mL MMC
Comparison intervention: EX‐DCR
Outcomes Measured outcomes:
  • functional success, defined as the relief of epiphora

  • anatomic success, defined as patency to lacrimal irrigation

  • intraoperative complications


Adverse events: injury to nasal mucosa, sac injury, severe bleeding, epistaxis, wound infection
Identification Author name: Andleeb Ahangar
Institution: Department Of Ophthalmology, Government Medical College Srinagar
Email: andleebali@gmail.com
Notes Funding source: not reported
Declarations of interest: none
Trial registration number: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Method of random sequence generation was not reported.
Allocation concealment (selection bias) Unclear risk Method of allocation concealment was not reported.
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk Masking of participants and personnel was not reported.
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Masking of outcome assessors was not reported.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk There were no missing outcome data.
Selective reporting (reporting bias) Unclear risk No trial or protocol registration available for comparison to ascertain selective outcome reporting.
Other bias Unclear risk There was insufficient information to permit a judgement of 'low risk' or 'high risk'.